EU approves use of 3rd dose of Moderna vaccine in immunodeficient

12

According to Moderna, the third dose must be administered at least 28 days after the second dose of the vaccine

A Modern announced on Tuesday, 5, in a statement on its website, that the European Medicines Agency (EMA) authorized the administration of a third dose of the vaccine against covid-19 developed by the pharmaceutical company to immunodeficient people in the territory gives European Union (EU).

  • Want to know all about covid-19 vaccine development and effectiveness? Sign the EXAM and stay inside.

According to the company, the third dose should be administered at least 28 days after the second dose of the vaccine, in order to reinforce protection in “severely immunocompromised individuals aged 12 years or more”.

According to the American drugmaker, a “growing number” of studies have shown the benefits of a third dose in people with immune systems that have a less robust response to vaccines.

Thanks for reading the EXAM! How about becoming a subscriber?

Get unlimited access to the best content of your day. In just a few minutes, you create your account and continue reading this article. Come on?

It’s just a moment before you release your access.

digital exam

BRL 4.90/month
  • R$ 14.90 from the second month.
  • Access whenever and wherever you want.
  • Unlimited access to EXAME Invest, macroeconomics, markets, career, entrepreneurship and technology.

Sign it

annual digital exam

BRL 129.90/year
  • R$ 129.90 in cash or in up to 12 installments. (BRL 10.83 per month)
  • Access whenever and wherever you want.
  • Unlimited access to EXAME Invest, macroeconomics, markets, career, entrepreneurship and technology.

Sign it

palheta smll EU approves use of 3rd dose of Moderna vaccine in immunodeficient

See too

4236276